用INLA进行贝叶斯生存分析
Danilo Alvares1, Janet van Niekerk2, Elias Teixeira Krainski2
1MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Statistics in medicine
|June 26, 2024
概括
本教程展示了使用R包集成嵌套拉普拉斯近似法 (INLA) 拟合贝叶斯生存模型. 它涵盖了各种模型,为生存分析中的快速和准确的贝叶斯推理提供了语法示例.
科学领域:
- 生物统计学 生物统计学
- 计算统计学 计算统计学
- 生存分析的分析.
背景情况:
- 贝叶斯生存分析为建模时间到事件数据提供了一个灵活的框架.
- 传统的方法可能是计算密集型,特别是复杂的模型.
- 集成嵌套拉普拉斯近似 (INLA) 为贝叶斯推理提供了一个有效的替代方案.
研究的目的:
- 提供清晰的语法示例,以适应使用INLA的各种贝叶斯生存模型.
- 为了说明INLA和INLA联合R包用于生存数据分析的应用.
- 为纵向半连续标记,反复事件和终端事件展示一种新的联合模型.
主要方法:
- 使用集成嵌套拉普拉斯近似 (INLA) 进行近似贝叶斯推理.
- 通过INLA和INLA联合R包实施生存模型.
- 应用既有模型 (加速失效时间,比例危险,混合治愈,竞争风险,多状态,脆弱性) 和一个新的联合模型.
主要成果:
- 使用INLA演示了各种贝叶斯生存模型的实际实施.
- 为加速失效时间,比例危险,混合治愈,竞争性风险,多状态和脆弱性模型提供可重现的语法示例.
- 成功说明了复杂的纵向和生存数据场景的新联合模型.
结论:
- INLA为贝叶斯生存分析提供了一个快速而准确的方法.
- INLA和INLA联合R套餐促进了先进的生存模型的实施.
- 本教程是研究人员将贝叶斯方法应用于生存数据的实用指南.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
408
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
408
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Introduction To Survival Analysis
214
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
214
Comparing the Survival Analysis of Two or More Groups
176
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
176
Truncation in Survival Analysis
191
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
191
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342


